• Doença afeta cerca de 35 mil brasileiros[1]
[1] Guia de Discussão sobre Esclerose Múltipla no Brasil – Juntos para um Novo Futuro. Acesse em: www.guiadaem.com.br
[2] Luna G et al. JAMA Neurol. 2019;77(2).
[3] Loebermann M et al. Nature Rev Neurol. 2012;8:143-151.
[4] Chevalier-Cottin E. Infect Dis Ther. 2020 Jun 24 [Epub ahead of print].
[5] Poljak M et al. Clin Microbiol Infect. 2014;20 Suppl 5:1.
[6] Farez M et al. Neurology. 2019;93:584-594.
[7] Ciotti J. Mult Scler Relat Disord. 2020 Aug 1;45:102439 [Epub ahead of print].
[8] Vetter V et al. Ann Med. 2018. 50:110-120.
[9] Neeta Garg1 & Thomas W. Smith2. An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Barin and Behavior. Brain and Behavior, 2015; 5(9)
[10] Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000;343(13):938-52.
[11] Cristiano E, Rojas J, Romano M, Frider N, Machnicki G, Giunta D, et al. The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review. Mult Scler. 2013;19(7):844-54.